Abstract
The correct treatment of postoperative pain, in the early period immediately following surgery, is founded on the following four principles: 1- correct diagnosis of the source and magnitude of nociception; 2- understanding of the relationship of ongoing nociception and other components of pain including anxiety, ethnocultural components, meaning, prior experience; 3- treatment by establishment and maintenance of drug level at active sites to achieve and maintain analgesia and anxiolysis as appropriate; 4- continued re-evaluation of the therapy and refinement of the approach. The PACU standard of cure requires a strict accordance between intra and postoperative analgesia. It requires "proactive preoperative plan" that includes: - preoperative patient evaluation; - discussion with a single patient on different treatment options; - patient and family education; - pre-emptive measures as indicated; - intra-operative multimodal analgesia; - a correct triage of analgesia, just after initial evaluation of vital parameters in PACU; - re-evaluation of analgesia plan, if analgesia is inadequate; - a new titration, intravenous or epidural way, in order to achieve a stable VAS < 3; - plan a new analgesia scheme or confirm a preoperative plan; - control of adverse events, related to analgesia plan (gastric bleeding and/or bleeding of the surgical wound site, NSAIDs-induced renal damage, respiratory depression, delayed canalisation, nausea, vomiting, excessive sedation, difficulty in bladder emptying, itchiness); - a transmission of analgesia plan to ward nurses; - a control quality for verify at prefixed times patients satisfaction level, analgesia performed, adverse effects percent, analgesia related, plan variations percent.
Keywords: analgesia, pacu, postoperative care, acute pain guidelines, adverse events analgesia related
Current Drug Targets
Title: Analgesia in PACU: Indications, Monitoring, Complications
Volume: 6 Issue: 7
Author(s): G. Savoia, E. Gravino, M. Loreto and A. Erman
Affiliation:
Keywords: analgesia, pacu, postoperative care, acute pain guidelines, adverse events analgesia related
Abstract: The correct treatment of postoperative pain, in the early period immediately following surgery, is founded on the following four principles: 1- correct diagnosis of the source and magnitude of nociception; 2- understanding of the relationship of ongoing nociception and other components of pain including anxiety, ethnocultural components, meaning, prior experience; 3- treatment by establishment and maintenance of drug level at active sites to achieve and maintain analgesia and anxiolysis as appropriate; 4- continued re-evaluation of the therapy and refinement of the approach. The PACU standard of cure requires a strict accordance between intra and postoperative analgesia. It requires "proactive preoperative plan" that includes: - preoperative patient evaluation; - discussion with a single patient on different treatment options; - patient and family education; - pre-emptive measures as indicated; - intra-operative multimodal analgesia; - a correct triage of analgesia, just after initial evaluation of vital parameters in PACU; - re-evaluation of analgesia plan, if analgesia is inadequate; - a new titration, intravenous or epidural way, in order to achieve a stable VAS < 3; - plan a new analgesia scheme or confirm a preoperative plan; - control of adverse events, related to analgesia plan (gastric bleeding and/or bleeding of the surgical wound site, NSAIDs-induced renal damage, respiratory depression, delayed canalisation, nausea, vomiting, excessive sedation, difficulty in bladder emptying, itchiness); - a transmission of analgesia plan to ward nurses; - a control quality for verify at prefixed times patients satisfaction level, analgesia performed, adverse effects percent, analgesia related, plan variations percent.
Export Options
About this article
Cite this article as:
Savoia G., Gravino E., Loreto M. and Erman A., Analgesia in PACU: Indications, Monitoring, Complications, Current Drug Targets 2005; 6 (7) . https://dx.doi.org/10.2174/138945005774574461
DOI https://dx.doi.org/10.2174/138945005774574461 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Books

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
TNF-α and IL-8 in Acute Stroke and the Modulation of these Cytokines by Antiplatelet Agents
Current Neurovascular Research Can Binding Kinetics Translate to a Clinically Differentiated Drug? From Theory to Practice
Letters in Drug Design & Discovery The Function of Tyrosine Hydroxylase in the Normal and Parkinsonian Brain
CNS & Neurological Disorders - Drug Targets Clinical Uses of Low – Dose Ketamine in Patients Undergoing Surgery
Current Drug Targets Renal Heat Shock Proteins Over-Expression Due to Anabolic Androgenic Steroids Abuse
Mini-Reviews in Medicinal Chemistry Kainic Acid-Induced Neurotoxicity: Targeting Glial Responses and Glia-Derived Cytokines
Current Neuropharmacology Editorial (Thematic Issues: Basic and Clinical Aspects of Melatonin in the Gastrointestinal Tract. New Advancements and Future Perspectives)
Current Pharmaceutical Design Advances in Antithrombotic Agents
Cardiovascular & Hematological Agents in Medicinal Chemistry Inosine 5'-Monophosphate Dehydrogenase (IMPDH) as a Potential Target for the Development of a New Generation of Antiprotozoan Agents
Mini-Reviews in Medicinal Chemistry Involvement of the Blood-Brain Barrier in Metabolic Regulation
CNS & Neurological Disorders - Drug Targets Synthetic Peptides in the Diagnosis of Systemic Autoimmune Diseases
Current Protein & Peptide Science Levosimendan: A Novel Agent in Heart Failure
Recent Patents on Cardiovascular Drug Discovery Editorial
Current Medicinal Chemistry - Anti-Infective Agents The Induction of Proinflammatory Cytokines in Response to Avian Influenza H5N1 Infections and their Role in Pathogenesis and the Enhancement of Virulence
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Editorial (Thematic Issue: Ceramics, Nanotubes, Advanced Materials: Theoretical and Experimental Structure-Property Relationships Part IV)
Current Physical Chemistry Clearance of Amyloid-β Peptide Across the Choroid Plexus in Alzheimer's Disease
Current Aging Science Dietary Modulation of Thymic Enzymes
Endocrine, Metabolic & Immune Disorders - Drug Targets Study of the Interaction Between Fisetin and Human Serum Albumin: A Biophysical Approach
Protein & Peptide Letters Current Strategies to Achieve Further Cardiac and Renal Protection through Enhanced Renin-Angiotensin-Aldosterone System Inhibition
Reviews on Recent Clinical Trials NPY Family of Hormones: Clinical Relevance and Potential Use in Gastrointestinal Disease
Current Topics in Medicinal Chemistry